Mark A. Keibler
Alnylam Pharmaceuticals (United States)(US)Massachusetts Institute of Technology(US)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Metabolism, Diabetes, and Cancer, Cancer, Lipids, and Metabolism, Metabolomics and Mass Spectrometry Studies, Pancreatic function and diabetes
Most-Cited Works
- → Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer(2016)746 cited
- → Reductive glutamine metabolism is a function of the α-ketoglutarate to citrate ratio in cells(2013)361 cited
- → The metabolic function of cyclin D3–CDK6 kinase in cancer cell survival(2017)350 cited
- → Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors(2016)328 cited
- → A self-assembling hydrophobically modified chitosan capable of reversible hemostatic action(2011)241 cited
- → Metabolic requirements for cancer cell proliferation(2016)130 cited
- → Aldehyde dehydrogenase 3a2 protects AML cells from oxidative death and the synthetic lethality of ferroptosis inducers(2020)112 cited
- → Akt regulation of glycolysis mediates bioenergetic stability in epithelial cells(2017)75 cited
- → Merkel Cell Polyomavirus Small T Antigen Promotes Pro-Glycolytic Metabolic Perturbations Required for Transformation(2016)72 cited
- → Review of metabolic pathways activated in cancer cells as determined through isotopic labeling and network analysis(2017)63 cited